1Natali A, Vichi S, Landi P, et al. Coronary atherosclerosis in type 2 diabetes:Angiographical findings and clinical outcome.Diabetologia,2000;43(5):632.
2Johansen OE, Birkeland KI. Preventing macrovascular disease in patients with type 2 diabetes mellitus.Am J Cardiovasc Drugs,2003;3(4):283.
3Hopkins PN, Wu LL, Hunt SC, et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease.Arterioscler Thromb Vasc,1996;16(2):250.
4Syvanne M, Pajunen P, Kahri J, et al. Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects.Coron Artery Dis,2001;12(2):99.
5Kendall DM, Harmel AP. The metabolic syndrome, type 2 diabetes, and cardiovascular disease:understanding the role of insulin resistance.Am J Manag Care,2002;8(20 Suppl):s 635.
6Kaur J, Singh P, Sowers JR. Diabetes and cardiovascular disease.Am J Ther,2002;9(6):510.
7McGarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes,2002;51(1):7.
